Investors seem to have not done their reearch on current treatment for liver disease ie: HCV ... IMO
Results of liver function tests qualitive/quantative data ALT AST levels in particular ... these results will determine efficacy of treatment.
Viral load PCR quantity IU/ml of blood detectable HCV virus in patients blood stream.
Recognised worldwide in clinical trials as leading indicators.
Where are these results?
need more than the quarterly, page-23
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)